SCHEMBL25668607

SCHEMBL25668607

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccc6ccccc6c5)cc4)nc(-c4cccc5c(-c6cccc7ccccc67)cccc45)n3)c3c2oc2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MAPT P10636 4/20 0.38
KDM4E B2RXH2 3/20 0.38
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CDC14B O60729 2/20 0.37
CDC14A Q9UNH5 2/20 0.37
PIM1 P11309 3/20 0.36
CYP1A2 P05177 2/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24887647 0.96 CDC14B (0.38) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23820174 0.96 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23821858 0.95 ALDH1A1 (0.39) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23820642 0.95 ALOX5 (0.41) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23822271 0.94 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23821964 0.94 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23820633 0.94 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23820534 0.93 CDC14B (0.41) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23821961 0.93 CDC14B (0.41) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23816389 0.93 CDC14B (0.41) ALDH1A1MAPTKDM4ETP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 US disclosed
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 ALDH1A1 133/4885MAPT 958/4885KDM4E 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.